LABOMAR S.p.A.

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about LABOMAR S.p.A.

Is LABOMAR S.p.A. on an FDA import alert?

No listing for LABOMAR S.p.A. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Italy page.

Has FDA refused shipments from LABOMAR S.p.A.?

Yes. FDA refused 2 shipment lines from LABOMAR S.p.A. between February 21, 2018 and March 10, 2022. The most recent, on March 10, 2022, was vitamin b2 (riboflavin), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse LABOMAR S.p.A.'s shipments?

The most frequent charges are NUTRIT LBL (nutrition information missing from label, 1 line) and UNAPPROVED (unapproved new drug, 1 line).

When was LABOMAR S.p.A. last inspected by FDA?

FDA's most recent inspection of LABOMAR S.p.A. with a final classification is dated September 12, 2025 and was classified NAI (No Action Indicated).

What is LABOMAR S.p.A.'s FEI number?

LABOMAR S.p.A.'s FDA Establishment Identifier (FEI) is 3011280506.